Avoiding Obstacles When Outsourcing Your Nonclinical Research

In biopharmaceutical development, demonstrating efficacy and toxicity is a critical milestone on the path to entering human clinical trials. However, many companies lack the internal resources to manage all aspects of their nonclinical development, often relying on outsourcing to nonclinical contract research organizations (CROs). Successfully navigating the technical challenges of outsourcing is vital for ensuring your program stays on track and avoids delays that could jeopardize meeting key milestones.

In this on-demand webinar, Altasciences Senior Scientific Advisor for Safety Assessment, Scott E. Boley, PhD, DABT, provides valuable insights into how drug developers can effectively plan for obstacles in outsourcing nonclinical research. Learn how to avoid critical missteps by establishing clear communication and protocols, selecting the right CRO, optimizing your pre-IND meeting, and ensuring your CRO has the necessary information about your test article. This guidance can make all the difference in bringing your drug to market efficiently and successfully.